Resveratrol can also regulate the expression of Fas and SREBP-1c, SCD, ACC, and reduce triglycerides and insulin resistance in fructose-induced NAFLD through activating SIRT1 [61]. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.